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10  per  100,000.    The  male  to  female  ratio  in  Northern 
Ireland of pancreatic cancer diagnosis is 1.3:1. It carries a 
bleak  prognosis,  with  less  than  3%  surviving  three  years 
following  diagnosis.1        The  Campbell  report  “Cancer 
services  –  investing  for  the  future”,  published  in  2001, 
sought to address the provision of treatment for cancer and 
made  several  recommendations.2   Although  centralisation 
of pancreatic surgical services in Northern Ireland has not 
been  fully  implemented,  there  has  been  an  establishment 
of  a  multidisciplinary  approach  to  cancer  treatment, 




standard  since  2001.    The  involvement  of  oncologists, 
gastroenterologists,  pancreatic  surgeons,  interventional 
radiologists, palliative care physicians and the primary care 
team in multidisciplinary discussion has resulted in improved 





































The  common  bile  duct  (CBD)  is  formed  by  the  left  and 
right hepatic duct at the hilar confluence.  It travels down 

























tumours  of  the  pancreas  are  less  common  and  presenting 
symptoms relate to the hormone being secreted.
























pancreaticoduodenectomy  specimen,  namely  the  anterior, 
posterior  and  superior  mesenteric  vein  (SMV)  groove 
surfaces.  At pathological evaluation, the specimen is usually 


































ultrasound,  computerised  tomography,  endoscopic  and 
intraoperative ultrasound. The two important categories of 
management are chemotherapy and surgery.  The latter alone 
offers  potential  cure,  but  the  late  presentation  of  disease 
renders many patients unresectable.  The role of chemotherapy 
can be either palliative or as an adjunct to surgery.
The  surgical  procedure  is  a  pancreaticoduodenectomy,  or 
Whipple’s procedure (Figure 2).  This is named after Allen 
Oldfather Whipple (1881-1963), who pioneered the resection, 






gastrojejunostomy.    Total  pancreatectomy  is  not  usually 
recommended  and  often  leads  to  brittle  diabetes.    An 
important  modification  of  the Whipple’s  procedure  is  the 
pylorus-sparing pancreaticoduodenectomy.8
The aim of this retrospective study was to determine the 
































One  hundred  and  seventy-four  patients,  underwent  a 











Fifteen  patients  underwent  distal  pancreatectomy  for 





During  the  study  period  106  Whipple’s  procedures  were 
performed by three consultant surgeons.  The average age 
of the patients was 61.7 years (± 11.7).  The operation was 






months. The  number  of  Whipple’s  procedures  performed 
annually  has  increased  during  the  study  period,  with  a 
decreasing trend of mortality, with no deaths in the last 3 years 
of the study period out of 52 operations.
Whipple’s patients and survival trends
Histologically 92 of the 100 tumours proved to be ductal 




























demonstrated  tumour  differentiation  (p=0.001)  and  nodal 
status  (p<0.001)  were  the  only  significant  predictors  of 
mortality.    Log-rank  test  revealed  perineural  invasion 




lymphovascular  invasion  (1.97),  positive  resection  margin 
(2.01) and positive nodal status (2.79).
dIscussIon
Pancreaticoduodenectomy  is  a  major  operation,  carrying 
significant risk of morbidity and mortality.  Complications 
include delayed gastric emptying (20%), wound infection 
(10%)  and  intra-abdominal  collections  or  fistulae  (15%).   
The  latter  is  often  secondary  to  anastomotic  breakdown, 










in  these  patients,  some  authors  advocate  the  less  radical 
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operative determination of the site of the tumour is often 





The  involvement  of  the  resection  margin,  known  as  R1 




















evidence  reveals  that  the  ratio  of  metastatically  involved 
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